BCL2 and acute myeloid leukemia: Previous study demonstrated that the IC50 of venetoclax was inversely correlated with Bcl-2/Mcl-1 transcript ratio, and over-expression of Bcl-xl or Mcl-1 conferred resistance to venetoclax-induced apoptosis in AML cell lines [27].